COVID-19
better trustworthiness of clinical evidence through clinical trials and systematic reviews
Downloads
References
Althouse AD. How Did This Pass Peer Review? Thoughts on the Lancet and NEJM COVID-19 Retractions. Medscape. 2020. Available from: Available from: https://www.medscape.com/viewarticle/932262 Accessed in 2020 (Jun 18).
Chatterjee P, Anand T, Singh KJ, et al. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. Indian Journal of Medical Research. [Epub ahead of print]. Available from: Available from: http://www.ijmr.org.in/preprintarticle.asp?id=285520 Accessed in 2020 (Jun 18).
Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-8. PMID: 32286245; doi: 10.1515/cclm-2020-0369.
Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202-5. PMID: 32217834; doi: 10.1172/JCI137647.
Randomised Evaluation of COVID-19 Therapy (RECOVERY). University of Oxford; 2020. Available from: Available from: https://clinicaltrials.gov/ct2/show/NCT04381936 Accessed in 2020 (Jun 18).